Renal Cancer - Results from #4760

Bilateral renal cell carcinoma with leiomyomatous stroma: A rare entity diagnosed synchronously and treated surgically in a staged fashion January 10, 2018

Poor Risk Advanced Renal Cell Carcinoma: Outcomes from a Registry in a Tertiary Cancer Center January 10, 2018

A multidisciplinary approach for the management of earlier stage renal cell carcinoma January 10, 2018

Metastatic Renal Cell Cancer to Thyroid Diagnosed by Endoscopic Ultrasound Guided Fine Needle Aspiration Technique January 10, 2018

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma January 9, 2018

Gene expression analysis in peripheral blood cells of patients with hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC): identification of NRF2 pathway activation January 9, 2018

Genetic polymorphisms associated with adverse reactions of molecular-targeted therapies in renal cell carcinoma January 9, 2018

Body mass index and 20-specific cancers: re-analyses of dose-response meta-analyses of observational studies January 8, 2018

Quantitative Contour Analysis as an Image-Based Discriminator between Benign and Malignant Renal Tumors January 8, 2018

The developmental programme for genesis of the entire kidney is recapitulated in Wilms tumour January 8, 2018

Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy January 8, 2018

Plasmatic miR-210, miR-221 and miR-1233 profile: potential liquid biopsies candidates for renal cell carcinoma January 5, 2018

Pathological upstaging of clinical T1 renal cell carcinoma: an analysis of 115,835 patients from National Cancer Data Base, 2004-2013 January 5, 2018

Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis January 5, 2018

Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients January 4, 2018

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry January 4, 2018

How Checkpoint Inhibitors Are Changing the Treatment Paradigm in Solid Tumors: What Advanced Practitioners in Oncology Need to Know January 3, 2018

Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: a comprehensive observation in radical nephrectomy specimens January 3, 2018

Assessment of Treatment Patterns for Metastatic Renal Cell Carcinoma in Brazil January 3, 2018

Cabozantinib: A Multi-targeted Oral Tyrosine Kinase Inhibitor January 2, 2018

Page 239 of 458